Intestinal Permeability Is Regulated by a Single Protein — Zonulin — Discovered by Alessio Fasano in 2000, and Its Release by Gliadin and Gut Bacteria Opens Epithelial Tight Junctions, Allowing LPS Endotoxin to Translocate Into Circulation and Drive Systemic Inflammation Linked to Metabolic Syndrome, Autoimmunity, and Neuroinflammation — The Evidence for Gut Barrier Repair With L-Glutamine, Butyrate, Zinc Carnosine, and Lactobacillus rhamnosus GG Is Mechanistically Grounded and Clinically Supported
Updated: June 2026leaky gut · leaky gut syndrome · intestinal permeability · gut permeability · gut barrier · intestinal barrier · tight junctions · tight junction proteins · leaky gut science · is leaky gut real · leaky gut evidence · leaky gut research · leaky gut medical · leaky gut controversy · leaky gut cause or effect · leaky gut and disease · leaky gut and inflammation · leaky gut and autoimmune · leaky gut and brain · leaky gut and metabolic syndrome · leaky gut and obesity · leaky gut and diabetes · zonulin · zonulin protein · zonulin intestinal permeability · zonulin Fasano · Fasano zonulin · Fasano 2000 · Fasano tight junctions · Fasano leaky gut · zonulin discovery · zonulin gliadin · zonulin bacteria · zonulin CXCR3 · CXCR3 zonulin · zonulin release mechanism · zonulin serum · serum zonulin test · zonulin blood test · claudin · occludin · ZO-1 · tight junction claudin · tight junction occludin · tight junction ZO-1 · claudin-1 · claudin-3 · claudin-4 · CLDN1 · CLDN3 · paracellular permeability · transcellular permeability · intestinal epithelium tight junctions · epithelial tight junctions · junctional complex · adherens junctions · desmosomes · LPS · lipopolysaccharide · LPS endotoxin · endotoxemia · metabolic endotoxemia · LPS systemic inflammation · LPS translocation · LPS and obesity · LPS and insulin resistance · LPS and type 2 diabetes · bacterial LPS · gram-negative bacteria LPS · endotoxemia fatty meal · LPS after high fat meal · Cani 2007 endotoxemia · Cani metabolic endotoxemia · lactulose mannitol ratio · lactulose mannitol test · intestinal permeability test · gut permeability test · leaky gut test · how to test for leaky gut · lactulose mannitol ratio normal · serum LPS gut permeability · leaky gut celiac · gliadin leaky gut · gluten leaky gut · gluten intestinal permeability · gliadin zonulin · gluten zonulin · celiac disease intestinal permeability · non-celiac gluten sensitivity permeability · leaky gut IBS · IBS intestinal permeability · IBS-D leaky gut · leaky gut Crohn · Crohn disease intestinal permeability · IBD leaky gut · leaky gut glutamine · L-glutamine leaky gut · glutamine gut barrier · glutamine tight junctions · Wischmeyer glutamine · leaky gut butyrate · butyrate tight junctions · butyrate claudin · butyrate gut barrier · leaky gut zinc carnosine · zinc carnosine gut · zinc carnosine tight junctions · zinc carnosine PepZin GI · leaky gut Lactobacillus rhamnosus GG · LGG tight junctions · Lactobacillus GG leaky gut · LGG intestinal permeability · probiotics leaky gut · probiotics tight junctions · leaky gut protocol · gut barrier repair · leaky gut supplement · leaky gut diet · leaky gut treatment · gut healing protocol · how to fix leaky gut · leaky gut and food · inflammatory diet leaky gut · NSAID leaky gut · NSAIDs intestinal permeability · alcohol leaky gut · alcohol gut barrier · stress leaky gut · stress cortisol gut
The intestinal epithelium — a single-cell layer covering approximately 32 square meters of mucosal surface — is the largest interface between the human body and the external environment. It must simultaneously absorb nutrients while maintaining an impermeable barrier against dietary antigens, microbial products, and toxins. This selectivity is maintained by tight junction complexes: multiprotein structures at the apical junctions between adjacent epithelial cells that seal the paracellular space (the space between cells). Tight junctions are not static seals; they are dynamically regulated protein networks that can open and close in response to physiological signals — and, under pathological conditions, can become dysregulated in ways that compromise barrier function.
The central discovery that transformed this field was made in 2000 by Alessio Fasano and colleagues at the University of Maryland School of Medicine: zonulin, the first — and to date only — known endogenous protein that reversibly regulates tight junction permeability throughout the gastrointestinal tract. Before the discovery of zonulin, tight junction regulation was poorly understood, and the concept of "leaky gut" was largely clinical anecdote without a molecular mechanism. Zonulin provided the mechanism: a protein that, when released by the intestinal mucosa in response to specific stimuli (bacterial colonization of the small intestine, certain dietary proteins), binds to EGF receptor and CXCR3 on epithelial cells, triggering a MyoD/protein kinase C-dependent cascade that phosphorylates tight junction proteins and causes their disassembly — opening the paracellular space to molecules that would otherwise be excluded.
Zonulin Mechanism
how gliadin opens the gut barrier — Fasano A et al. (2000, Lancet): identified zonulin as a tight junction regulator; later characterization: zonulin is pre-haptoglobin 2 (pHP2), a precursor form of haptoglobin released from the liver; its intestinal concentration is regulated by mucosal release; GLIADIN PATHWAY (the most studied trigger): STEP 1: dietary gliadin (a wheat gluten component) reaches the intestinal lumen; STEP 2: gliadin peptides (specifically the gliadin 31-49 and 57-89 peptide fragments) bind CXCR3 receptors on the apical surface of intestinal epithelial cells; STEP 3: CXCR3 activation → MyoD kinase activation → phosphorylation of tight junction-associated proteins; STEP 4: zonulin is released from epithelial cells and enterocytes → binds EGF receptor on neighboring cells → PKCα activation → ZO-1 redistribution from the tight junction complex; STEP 5: claudin and occludin are disassembled from the ZO-1 scaffold → paracellular space opens → molecules >70 kDa can now translocate; STEP 6: in celiac disease (where gliadin triggers an immune cascade), elevated zonulin is both a cause and amplifier of the barrier disruption; in non-celiac individuals, gliadin also transiently opens tight junctions (Drago 2006) — but the opening resolves within 4 hours; BACTERIAL TRIGGER: overgrowth of bacteria in the small intestine (SIBO) also triggers zonulin release — the mechanism is thought to be a defensive response to limit bacterial entry by triggering immune cell egress into the intestinal lumen; CLINICAL ELEVATION: zonulin is elevated in celiac disease (7× normal), T2DM, obesity, IBS-D, ankylosing spondylitis, and multiple sclerosis — suggesting gut permeability is a shared feature across metabolically and immunologically diverse conditions
Tight Junction Proteins
the structural components — the tight junction complex comprises four classes of transmembrane proteins cross-linked by scaffold proteins: CLAUDINS (the selectivity backbone): ~27 family members with different tissue distributions; claudin-1, -3, -4: barrier-forming claudins (their overexpression tightens TJs); claudin-2: channel-forming claudin (its overexpression opens paracellular channels for ions and water — elevated in IBD); claudin-1 specifically: butyrate induces claudin-1 expression in colonocytes; statin treatment lowers claudin-2 in IBD (emerging research); OCCLUDIN: transmembrane protein integral to TJ function; its phosphorylation state regulates TJ opening; dephosphorylation → TJ opening; alcohol causes occludin dephosphorylation and redistribution; CLDN1/CLDN3 are lost from epithelium in Crohn disease, restored by successful therapy; JUNCTIONAL ADHESION MOLECULES (JAMs): JAM-A, JAM-B, JAM-C: single-pass transmembrane proteins at TJs; regulate paracellular permeability and immune cell diapedesis; ZO-1, ZO-2, ZO-3 (Zonula Occludens proteins): scaffold proteins that anchor claudins and occludin to the actin cytoskeleton; ZO-1 is the master organizer — when ZO-1 redistributes from the membrane to the cytoplasm, TJs disassemble; ZO-1 expression reduced in IBS-D, Crohn disease, celiac disease; MYOSIN LIGHT CHAIN KINASE (MLCK): contracts the perijunctional actomyosin ring → TJ opening; the primary effector of cytokine (TNF-α, IL-1β, IFN-γ) driven gut permeability increases; MLCK inhibitors are in early development for IBD
Metabolic Endotoxemia
LPS, fat, and systemic inflammation — Cani PD et al. (2007, Diabetes): the foundational "metabolic endotoxemia" study; used a high-fat diet in mice to demonstrate that: (1) a high-fat diet increases serum LPS (lipopolysaccharide — the cell wall component of gram-negative bacteria) by 2–3×; this low-grade increase in circulating LPS is termed "metabolic endotoxemia"; (2) the LPS elevation was causally linked to high-fat diet via increased intestinal permeability (fat digestion products, especially lysophosphatidylcholine, transiently open TJs) and increased chylomicron-mediated LPS transport (fat absorption in chylomicrons acts as a Trojan horse for LPS); (3) continuous low-dose LPS infusion alone (without high-fat diet) reproduced: +2–3× fasting insulin, increased adipose tissue inflammation, increased body weight, impaired glucose tolerance, increased liver steatosis; MECHANISM: LPS binds TLR4 (Toll-like receptor 4) on macrophages, adipocytes, hepatocytes, and endothelial cells → NF-κB activation → TNF-α, IL-6, IL-1β secretion → systemic low-grade inflammation; adipose TLR4 activation specifically: promotes adipose inflammation, insulin receptor substrate (IRS-1) serine phosphorylation → insulin resistance; HUMAN EVIDENCE: Pendyala S et al. (2012): high-fat Western diet in healthy adults × 1 month → 71% increase in serum LPS; Moreno-Navarrete JM et al.: circulating LPS levels correlate with BMI, HOMA-IR, and inflammatory markers in human cohorts; the metabolic endotoxemia framework explains why gut dysbiosis → inflammation → metabolic syndrome is a plausible causal pathway (not just correlation)
Gut Barrier Repair
evidence-based interventions — four most mechanistically grounded and clinically supported repair strategies: L-GLUTAMINE: the primary fuel of enterocytes (intestinal cells); approximately 40% of circulating glutamine is extracted by the intestinal mucosa on first pass; glutamine depletion → enterocyte atrophy → barrier dysfunction; Wischmeyer PE et al. (2003): critical illness and GI surgery glutamine supplementation prevents intestinal permeability increases; mechanism: glutamine → nucleotide synthesis for epithelial cell renewal; glutamine → GSH (glutathione) synthesis → reduced oxidative damage to TJ proteins; Sevastiadou S et al. (2011, J Neonatal-Perinatal Med): NICU neonates, glutamine × 30 days: reduced intestinal permeability (lactulose:mannitol ratio) vs placebo; DOSE: 5–15g glutamine daily in divided doses; take on empty stomach for direct mucosal delivery; BUTYRATE: short-chain fatty acid produced by gut bacteria fermenting fiber; colonocyte primary fuel (~70% of colonocyte energy from butyrate); specifically induces claudin-1 expression via PPARγ activation and HDAC inhibition → tighter TJs; Peng L et al. (2009, J Nutr): butyrate upregulated occludin and claudin-1 in Caco-2 cells and in vivo; ZINC CARNOSINE (PepZin GI): chelate of zinc and L-carnosine; Mahmood A et al. (2007, Gut): N=10 healthy volunteers, zinc carnosine × 1 week before NSAID course: prevented NSAID-induced intestinal permeability increase (lactulose:mannitol) vs placebo; mechanism: carnosine → metal chelation in gut lumen + anti-inflammatory; zinc → metallothionein induction → mucosal protection; LACTOBACILLUS RHAMNOSUS GG (LGG): the most-studied probiotic for gut barrier; Mennigen R et al. (2009, J Physiol): LGG prevents cytokine-induced TJ disruption in vitro; Sindhu KN et al. (2014, Eur J Clin Nutr): children with acute diarrhea, LGG × 5 days: decreased intestinal permeability vs placebo; LGG produces p40 molecule → EGFR activation → protective effect on TJs and epithelial survival
Ready to fix this at the root?
The 30-Day Gut Reset is the full day-by-day protocol — mechanisms, dosed repair steps, a diagnostic chapter, food/swap tables, and a maintenance plan, built from the same research on this page.
Get the Gut Reset → $19
Gut Barrier Stressors and Protective Factors
| Factor | Effect on Gut Barrier | Mechanism | Evidence Level |
|---|
| NSAIDs (ibuprofen, aspirin) | Increases permeability | Prostaglandin inhibition → reduced mucosal blood flow; COX-1 inhibition → reduced mucus and bicarbonate secretion; direct phospholipid disruption | Strong (RCTs, lactulose:mannitol) |
| Alcohol | Increases permeability | Acetaldehyde → occludin dephosphorylation + redistribution; oxidative stress → TJ protein oxidation; direct enterocyte toxicity | Strong (human studies) |
| High-fat diet (acute) | Transient increase | Fat digestion products open TJs; chylomicron-mediated LPS absorption; bile acid changes | Moderate (animal + human) |
| Psychological stress | Increases permeability | CRH → mast cell degranulation → histamine → TJ opening; cortisol → MLC phosphorylation; sympathetic nervous system → reduced mucosal blood flow | Moderate (animal strong; human moderate) |
| L-Glutamine | Protective/restorative | Enterocyte energy substrate; GSH synthesis; nucleotide supply for epithelial renewal | Moderate (RCTs in surgical/critical care, less in healthy) |
| Butyrate (fermentable fiber) | Protective | Colonocyte fuel; claudin-1 upregulation; PPARγ activation; HIF-1α stabilization | Strong (in vitro + animal; human correlational) |
| Zinc carnosine | Protective | Mucosal zinc + anti-inflammatory carnosine; metallothionein induction | Moderate (Mahmood 2007 RCT) |
| Lactobacillus rhamnosus GG | Protective | p40 molecule → EGFR → epithelial survival; ZO-1 and claudin stabilization | Moderate (multiple RCTs) |
Gut Barrier Testing and Repair Protocol
Testing gut permeability: the lactulose:mannitol (L:M) ratio test is the established clinical and research standard for small intestinal permeability; METHOD: fast 4–6 hours; drink a solution of lactulose (a large disaccharide, normally excluded) + mannitol (a small monosaccharide, normally absorbed); collect urine for 5–6 hours; measure urinary lactulose and mannitol concentrations; INTERPRETATION: in a normal gut, mannitol is absorbed (small molecules pass through cell membranes) while lactulose is excluded (too large for transcellular route, and the paracellular space is normally sealed); elevated L:M ratio = more lactulose passed via leaky paracellular junctions relative to mannitol absorption; NORMAL: L:M ratio <0.03–0.07 (lab-specific); elevated in: celiac disease, Crohn disease, IBS-D, alcoholic liver disease, critical illness, NSAID users; SERUM MARKERS: serum zonulin (ELISA): elevated in intestinal permeability conditions; caveat — commercial zonulin assays have cross-reactivity issues (they may detect complement proteins, not just true zonulin/pHP2); interpret with clinical context; serum LPS or LPS-binding protein (LBP): elevated in metabolic endotoxemia; serum FABP2 (fatty acid binding protein 2 / I-FABP): released when enterocytes are damaged; elevated in acute gut injury; the combination of serum zonulin + LBP provides the most useful clinical picture of both TJ dysregulation and LPS translocation.
4-step gut barrier repair protocol: STEP 1 — REMOVE STRESSORS: eliminate or minimize NSAIDs (use acetaminophen as alternative where possible); reduce alcohol to <1 drink/day; address psychological stress (HPA axis CRH release directly opens TJs); address SIBO if suspected (lactulose or glucose breath test); STEP 2 — FEED ENTEROCYTES: L-glutamine 5–10g twice daily on empty stomach (morning and before sleep); this directly fuels the epithelial cell renewal cycle (the intestinal epithelium replaces itself every 5–7 days — constant substrate demand); STEP 3 — STRENGTHEN TIGHT JUNCTIONS: zinc carnosine 75mg twice daily with meals (PepZin GI form); probiotics: Lactobacillus rhamnosus GG 10–50 billion CFU/day; fermentable fiber 20–30g/day → butyrate production → claudin-1 upregulation; resistant starch (green banana, cooled potato starch) is particularly effective for butyrate production; STEP 4 — TEST AND RETEST: lactulose:mannitol ratio at baseline and 8–12 weeks; serum zonulin and LBP at baseline and 3 months; expect 3–6 months for measurable improvement in barrier function markers; hirsutism and hair loss from androgen-driven conditions won't respond until hormonal changes stabilize (parallel to the PCOS fertility restoration caveat above); FOOD-BASED SUPPORT: collagen protein (glycine + proline = gut barrier building blocks); bone broth (glycine-rich); fermented foods (kefir, sauerkraut → diverse Lactobacillus strains → barrier support); reduce ultra-processed food (emulsifiers polysorbate-80 and carboxymethylcellulose shown to disrupt mucus layer in animal models [Chassaing 2015 Nature]).
L-Glutamine for Gut Barrier →
Zinc Carnosine (PepZin GI) →
As an Amazon Associate, GutCode earns from qualifying purchases made through links on this page. This does not affect the price you pay.